QA: Bioxytran INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2015_Bioxytran_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
warning Excluding company: variable exceeds outlier threshold pre-agg {'variable': 'Expenses', 'value': 2348151, 'size_variable': 'Assets', 'size_value': 55816, 'ratio': 42.1, 'threshold': 20}

Graph

Absolute values for 0001445815, Bioxytran INC

  xvar xval
0 AssetsCurrent 6,168
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 107,115
3 remainder_Assets 0
4 LiabilitiesCurrent 334,735
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,390,340
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 165,977
11 remainder_Revenues 275,616
12 remainder_NetIncome -66,199
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 113,283
1 Liabilities 334,735
2 Expenses 1,556,317
3 Revenues 275,616
4 StockholdersEquity -221,452
5 NetIncome -1,346,900
6 ComprehensiveNetIncome -1,346,900
7 BaseVar 1,173,075
8 EconomicCapitalRatiobeforeLimitedLiability -8.17
9 EconomicCapitalRatio 0.00678

Edgar->Model Mapping

Feature Distribution

Change over Time